pharmaphorum

SEPTEMBER 30, 2020

The signatories of a new Biotech Social Pact with Europe and patients explain why healthcare calls for a new social contract, not a pharmaceutical strategy. As Europe continues its efforts to battle the Covid-19 pandemic, it is rightfully focusing its attention on the longer-term implications of this crisis. One common thread is clearly emerging from EU and national discussions: to reinforce Europe’s “strategic autonomy” and “technological sovereignty” in key industrial sectors.

141

141

Outsourcing Pharma

SEPTEMBER 28, 2020

Ena Respiratoryâs preventative nasal spray treatment could reach human trials within four months, following results from an animal study released today which showed the spray reduced COVID-19 replication by up to 96%.

133

133

Drug Patent Watch

SEPTEMBER 28, 2020

Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It is available from three suppliers. There are twenty-two patents protecting…. The post New patent for NOVO drug OZEMPIC appeared first on DrugPatentWatch - Make Better Decisions.

98

98

Pharma Times

SEPTEMBER 28, 2020

Insights from project could potentially improve precision medicine use for paediatric AML

132

132

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

SEPTEMBER 28, 2020

The FDA has launched its Digital Health Center of Excellence (DHCoE), as the agency continues with its commitment to advancing use of technology such as mobile health devices, software and wearables to create medical products. Housed within the agency’s Center for Devices and Radiological Health, the DHCoE is part of a wider strategy to encourage development of digital health products and therapeutics.

143

143

Outsourcing Pharma

SEPTEMBER 30, 2020

The companyâs Phase II trial of ultramicronized PEA has received FDA approval and expects to begin dosing patientparticipants as early as next month.

119

119

Pharma Times

SEPTEMBER 28, 2020

Drug is being investigated in up to 800 hospitalised patients nationwide

140

140

pharmaphorum

SEPTEMBER 30, 2020

Regeneron’s antibody cocktail seems to reduce levels of coronavirus and improve symptoms in patients, according to early test results. This first data comes from a descriptive analysis from the seamless phase 1/2/3 trial that Regeneron hopes will hurry the medicine dubbed REGN-COV2 to market. The ongoing double-blind trial measures the effect of adding REGN-COV2 to usual standard of care, compared with usual standard of care.

Immunization 135

Immunization Immunity 135

Outsourcing Pharma

SEPTEMBER 28, 2020

Results from the research indicate use of ACE in inhibitors and ARBs could prove useful in treating COVID-19 patients of African-American descent.

78

78

Pharma Mirror

SEPTEMBER 29, 2020

Ahead of the CPhI Festival of Pharma (5-16 October, 2020) – global pharma’s largest ever virtual gathering – the CPhI Pharma Index shows only Italy and India have improved their score in 2020, with the majority of industry executives looking for new supply chain partners. The Index – an aggregated confidence score across the five. The post Italy and India the only pharma economies to improve score in 2020 according to the CPhI Pharma Index appeared first on Pharma Mirror Magazine.

59

59

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharma Times

SEPTEMBER 29, 2020

First phase will see company deploy 300 PCR instruments to the UK

144

144

pharmaphorum

OCTOBER 1, 2020

For a long time, venture capital (VC) firms have been controlled mainly by men. But things are changing and women are becoming more influential in life sciences VCs, with an increase in business going to all-female teams. We spoke with two female VC leaders about how women could act as agents for change in this male-dominated world. Last year saw a record amount of venture capital – $17.2 billion – raised by women, according to the financial information company Pitchbook.

122

122

Outsourcing Pharma

SEPTEMBER 29, 2020

The companyâs studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.

76

76

Drug Patent Watch

SEPTEMBER 28, 2020

Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one NDA. There are ten patents protecting this drug. This drug…. The post New patent for Insmed Inc drug ARIKAYCE KIT appeared first on DrugPatentWatch - Make Better Decisions.

57

57

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharma Times

SEPTEMBER 28, 2020

Treatment is indicated for use in adults with moderate-to-severe active rheumatoid arthritis

125

125

pharmaphorum

SEPTEMBER 29, 2020

The pharmaceutical industry is one of the most scientifically innovative and competitive industries, particularly in oncology. As of 2018, there were over 1,100 cancer therapies in development, and as of 2020, 362 of them were cell and gene therapies. As a result, there is a need for continued innovation and increased efficiency in terms of drug development to manage cost, complexity and speed to provide potentially transformative therapies for cancer patients.

Drug Development 128

Drug Development Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 128

Outsourcing Pharma

SEPTEMBER 29, 2020

The companyâs studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.

64

64

Drug Patent Watch

OCTOBER 2, 2020

This chart shows the pharmaceutical companies with the most sponge dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most sponge dosed drugs…. The post Which pharmaceutical companies have the most sponge dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Dosage 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

SEPTEMBER 30, 2020

New report finds 60 cancer cases per day could be avoided in less wealthy areas

130

130

pharmaphorum

SEPTEMBER 28, 2020

Shares in UK biotech Valirx were up sharpy this morning after its lead drug VAL201 showed evidence of efficacy in advanced prostate cancer in its first clinical trial. The company reported results from 11 patents taking part in the phase 1/2 study which showed a 54.5% overall response rate with VAL201, with a promising safety and tolerability profile.

Hospitals 123

Hospitals 123

Drug Channels

OCTOBER 2, 2020

Today’s guest post comes from Jenna Mitby-Manning, Senior Director of Commercial Strategy & Insights, Access & Adherence at RxCrossroads by McKesson. Jenna explains how data-driven solutions accelerate time to therapy, improve patient outcomes, and allow biopharma companies to make informed strategic decisions. Click here to learn more about RxCrossroads' therapy access and adherence solutions.

52

52

Drug Patent Watch

OCTOBER 2, 2020

Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…. The post New patent expiration for Boehringer Ingelheim drug OFEV appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharma Times

SEPTEMBER 30, 2020

Supply chain agreements come before upcoming data readout

139

139

pharmaphorum

SEPTEMBER 29, 2020

UK Prime Minister Boris Johnson has told the UN General Assembly that the UK will donate £571 million ($735 million) to the COVAX scheme aimed at distributing COVID-19 vaccines fairly around the world. The lion’s share of that total – around £500 million – will be “for developing countries to protect themselves,” said the PM in a recorded speech given to the assembly, delivered just before the number of deaths due to coronavirus topped 1 million worldwide.

Vaccines 116

Vaccines 116

Pharma Mirror

OCTOBER 1, 2020

Since the in-person PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon is presenting its latest solutions at the virtually-hosted PACK EXPO Connects from November 9 to 13, 2020. In a series of video and Q&A sessions, Syntegon is showcasing its intelligent and sustainable technologies for the.

Packaging 52

Packaging 52

Drug Patent Watch

OCTOBER 1, 2020

This chart shows the pharmaceutical companies with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Spain? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

SEPTEMBER 30, 2020

New therapy granted a Promising Innovative Medicine designation by UK agency

124

124

pharmaphorum

SEPTEMBER 29, 2020

Apple’s latest ad campaign for its Apple Watch makes much of its ability to monitor health functions – but researchers are concerned it may encourage people to seek medical attention prematurely. A study of people who consulted a doctor after an abnormal pulse was detected by their device suggests it could lead to false positives that mean unnecessary healthcare visits, according to the team from the Mayo Clinic.

Mayo Clinic 121

Mayo Clinic 121

Pharma Mirror

OCTOBER 1, 2020

Ranitidine is a pharmaceutical drug that is categorized as a histamine antagonist, also called an H2 blocker, that has popularly been used to treat acid reflux. However, this medication had recently raised controversies when the Food and Drug Administration (FDA) announced a product recall of this drug from the market due to the presence of. The post 6 Reasons Why Ranitidine Is Harmful and How It Caused Cancer to Many appeared first on Pharma Mirror Magazine.

52

52

Drug Patent Watch

SEPTEMBER 30, 2020

This chart shows the pharmaceutical companies with the most patents in Eurasian Patent Organization. Patents must be filed in each country (or, in some cases regional patent office) where patent…. The post Which pharmaceutical companies have the most drug patents in Eurasian Patent Organization? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Times

SEPTEMBER 29, 2020

First subject dosed with new drug candidate from strategic collaboration

126

126